Skip to Content
Search Menu

Sofie Pohl

Sofie Pohl holds a Master's degree in Communication from Aalborg University and a Bachelor's degree in Health Promotion and Health Strategies & Communication from RUC.
Sofie Pohl is the Content Manager at BestPractice Nordic, responsible for coordinating and producing content.

Articles

Deucravacitinib, A New Oral Option for Patients with Moderate to Severe Psoriasis

  • / Sofie Pohl

Rechallenge of IO/TKI in Second-Line After IO/TKI in First-Line Will Not Add Any Benefits

/ Sofie Pohl
Kidney cancer

The Missing Link of Light Chain Smoldering Multiple Myeloma

/ Sofie Pohl
Myeloma

EADV24: New Research Confirms Link Between Stress and Psoriasis Relapse

/ Sofie Pohl
EADV24Psoriasis

EADV24: Breakthrough in Early Melanoma Detection Using Tumour-Specific Antibodies

/ Sofie Pohl
EADV24Melanoma

EADV24: Semaglutide Shows Promising Outcomes for Obese Patients with Hidradenitis Suppurativa

/ Sofie Pohl
EADV24Hidradenitis Suppurativa

ESMO24: Breastfeeding After Breast Cancer Treatment Is Safe

/ Sofie Pohl
Breast cancerESMO24

EHA24: Danish LBA Shows that Oral Vitamin C Might Improve OS for Patients with Early-Stage Myeloid Malignancies and Precursor Conditions

/ Sofie Pohl
EHA24

Trastuzumab Deruxtecan Significantly Improves Progression-Free Survival in Breast Cancer Patients Previously Treated with Endocrine Therapy

/ Sofie Pohl
ASCO24

Melflufen Is Safe and Effective in Patients with Alkylator-Refractory Disease

/ Sofie Pohl
Myelooma

Nivolumab + Cabozantinib Remains Standard of Care in First-Line Treatment for Advanced Renal Cell Carcinoma

/ Sofie Pohl
Kidney cancer
Load more
Back to top